Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
In December 1998, the FTC announced that it had secured a consent agreement barring ACAM from making claims that chelation therapy is effective against atherosclerosis or any other disease of the circulatory system
Jun Yin, an endocrinologist at the Pennington Biomedical Research Center, conducted a pilot study showing that Berberine significantly reduced hemoglobin A1c, fasting blood glucose, and lipid levels, with efficacy comparable to metformin
10.1016/j.redox.2019.101171 17 FormanH
Some people have reported worsening suicidal ideation, and given the known association between bariatric surgery and suicidality, these reports should be taken seriously and discussed with patients while we await further research on this potential connection
Make it automatic rather than something requiring daily decision-making